Treatment of hypovitaminosis D with pharmacologic doses of cholecalciferol, oral vs intramuscular; An open labeled RCT

Clinical Endocrinology

Volumn 78, Issue 2, 2013, Pages 210-216

  Zabihiyeganeh, Mozhdeh ^a   Jahed, Adel ^b   Nojomi, Marzieh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D; VITIN;

ABSCESS; ADULT; ARTICLE; CELLULITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN ATROPHY; SWELLING; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADMINISTRATION, ORAL; CHOLECALCIFEROL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84872107669     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04518.x     Document Type: Article

References (36)

1. Yetley, E.A., (2008) Assessing the vitamin D status of the US population. American Journal of Clinical Nutrition, 88, 558S-564S.
2. Hyppönen, E., &, Power, C., (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. American Journal of Clinical Nutrition, 85, 860-868.
3. Ann, P., Inez, S., Kerry, G., et al,. (2009) Vitamin D deficiency and its health consequences in Africa. Clinical Review in Bone and Mineral Metabolism, 13, 94-106.
4. Fraser, D.R., (2004) Vitamin D-deficiency in Asia. The Journal of Steroid Biochemistry and Molecular Biology, 89-90, 491-495.
5. Diamond, T.H., Eisman, J.A., Mason, R.S., et al,. (2005) Vitamin D and adult bone health in Australia and New Zealand: a position statement. Medical Journal of Australia, 182, 281-285.
6. Melhus, H., Snellman, G., Gedeborg, R., et al,. (2010) Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. The Journal of Clinical Endocrinology & Metabolism, 95, 2637-2645.
7. Pekkarinen, T., Turpeinen, U., Hamalainen, E., et al,. (2010) Serum 25(OH)D3 vitamin status of elderly Finnish women is suboptimal even after summer sunshine but is not associated with bone density or turnover. European Journal of Endocrinology, 162, 183-189.
8. Heshmat, R., Mohammad, K., Majdzadeh, S.R., et al,. (2008) Vitamin D Deficiency in Iran: a Multi-center Study among Different Urban Areas. Iranian Journal of Public Health, 37 (suppl 1), 72-78.
9. Garland, C.F., Comstock, G.W., Garland, F.C., et al,. (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet, 2, 1176-1178.
10. Grant, W.B., (2002) An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer, 94, 272-281.
11. Tuohimaa, P., Tenkanen, L., Ahonen, M., et al,. (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. International Journal of Cancer, 108, 104-108.
12. Merlino, L.A., Curtis, J., Mikuls, T.R., et al,. (2004) Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheumaisms, 50, 72-77.
13. Reis, J.P., von Mühlen, D., Miller, E.R., et al,. (2009) Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics, 124, e371-379.
14. Ginde, A.A., Mansbach, J.M., &, Camargo, C.A. Jr, (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine, 169, 384-390.
15. Mersch, P.P., Middendorp, H.M., Bouhuys, A.L., et al,. (1999) Seasonal affective disorder and latitude: a review of the literature. Journal of Affective Disorders, 53, 35-48.
16. Dawson-Hughes, B., Harris, S.S., Krall, E.A., et al,. (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New England Journal of Medicine, 337, 670-676.
17. Chapuy, M.C., Pamphile, R., Paris, E., et al,. (2002) Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporosis International, 13, 257-264.
18. Trivedi, D.P., Doll, R., &, Khaw, K.T., (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal, 326, 469.
19. Sanders, K.M., Stuart, A.L., Williamson, E.J., et al,. (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. Journal of American Medical Association, 303, 1815-1822.
20. Durazo-Arvizu, R.A., Dawson-Hughes, B., Sempos, C.T., et al,. (2010) Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. Journal of Nutrition, 140, 595-599.
21. Bischoff-Ferrari, H.A., Dietrich, T., Orav, E.J., et al,. (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. American Journal of Medicine, 116, 634-639.
22. Vieth, R., Ladak, Y., &, Walfish, P.G., (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. Journal of Clinical Endocrinology and Metabolism, 88, 185-191.
23. Holick, M.F., (2010) The vitamin D deficiency pandemic: a forgotten hormone important for health. Public Health Reviews, 32, 267-283.
24. Holick, M.F., Biancuzzo, R.M., Chen, T.C., et al,. (2008) Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-Hydroxyvitamin D. Journal of Clinical Endocrinology and Metabolism, 93, 677-681.
25. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., et al,. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 96, 1911-1930.
26. Papaioannou, A., Kennedy, C.C., Giangregorio, L., et al,. (2011) A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. BMC Musculoskeletal Disorders, 12, 135.
27. Pietras, S.M., Obayan, B.K., Cai, M.H., et al,. (2009) Vitamin D2 Treatment for vitamin D deficiency and insufficiency for up to 6 years. Archives of Internal Medicine, 169 (19), 1806-1808.
28. Wortsman, A., Matsuoka, L.Y., Chen, T.C., et al,. (2000) Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition, 72, 690-693.
29. Vieth, R., (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. American Journal of Clinical Nutrition, 69, 842-856.
30. Diamond, T.H., Ho, K.W., Rohl, P.G., et al,. (2005) Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Medical Journal of Australia, 183, 10-12.
31. Hackman, K.L., Gagnon, C., Briscoe, R.K., et al,. (2010) Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting. Medical Journal of Australia, 192, 686-689.
32. Giusti, A., Barone, A., Pioli, G., et al,. (2010) Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. Journal of American Geriatrics Society, 58 (8), 1489-95.
33. Hashemipour, S., Sarukhani, M.R., &, Asefzadeh, S., (2009) Effect of different doses of parenteral vitamin D3 on serum 25 (OH) D concentrations. Daru, 17 (suppl 1), 26-30.
34. Stephens, W.P., Klimiuk, P.S., Berry, J.L., et al,. (1981) Annual high-dose vitamin D prophylaxis in Asian immigrants. The Lancet, 2, 1199-1201.
35. Leventis, P., &, Kiely, P.D.W., (2009) The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scandinavian Journal of Rheumatology, 38, 149-153.
36. Shahrivari, M., Jahed, S.A., Zabihiyeganeh, M., et al,. (2011) Comparison of oral versus intramuscular treatment of vitamin D deficiency or insufficiency. Presented at European Congress of Endocrinology, ESE, Rotterdam, The Netherlands. Endocrine Abstracts, 26, P540.